logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Seth P. Lerner

baylor college of medicine
H指数:86
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG-1216 Phase 3 Trial

前列腺切除术后转移时间作为异时性mHSPC患者预后因素的评估：SWOG-1216 III期试验的二次分析

Prostate
IF2.5
2026-10-070
OAAI
Nicolas Sayegh; Yeonjung Jo; Umang Swami; Varun Nandakumar; Georges Gebrael; Zeynep Irem Ozay; Haoran Li; Krishnam Goel; Benjamin L. Maughan; Melissa Plets; Maha H. A. Hussain; Tanya B. Dorff; Primo N. Lara Jr.; Amir Goldkorn; Seth P. Lerner; Neeraj Agarwal
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer

多学科瑞士共识：肌层浸润性膀胱癌根治性膀胱切除及三联治疗后随访建议

Bladder Cancer
IF1.2
2026-01-010
PRE
Kaufmann, Ernest; Aeppli, Stefanie; Affentranger, Andres; Arnold, Nicolas; Arnold, Winfried; Aschwanden, Fabian; Balermpas, Panagiotis; Beyer, Jorg; Bieri, Uwe; Boormanns, Joost; Cathomas, Richard; Bari, Berardino De; Dressler, Marco; Engeler, Daniel S.; Erdmann, Andreas; Gallina, Andrea; Gomez, Silvia; Guckenberger, Matthias; Herrmann, Thomas; Hermanns, Thomas; Lucca, Ilaria; John, Hubert; Kessler, Thomas Matthias; Klein, Jan; Laouiti, Mohamed; Lauffer, David; Lerner, Seth Paul; Mattei, Agostino; Muntener, Michael; Nguyen, Daniel; Niederberger, Philipp; Papachristofilou, Alexandros; Prause, Lukas; Putora, Paul Martin; Reinhardt, Karsten; Salati, Emanuela; Sebe, Philippe; Shelan, Mohamed; Sigg, Silvan; Strebel, Rato Thomas; Templeton, Arnoud Jan; Vogl, Ursula; Wettstein, Marian Severin; Wyler, Stephen; Zihler, Deborah; Zilli, Thomas; Zwahlen, Daniel; Roth, Beat; Fankhauser, Christian Daniel
Intermediate-risk Non–muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group

非肌层浸润性膀胱癌的中危风险：国际膀胱癌小组关于定义、风险分层、管理策略和临床试验设计的建议

European Urology Oncology
IF9.3
2025-10-100
PRE
Roger Li; Patrick J. Hensley; Marko Babjuk; Laura Bukavina; Sarah P. Psutka; Seth P. Lerner; Michael A. O’Donnell; Yair Lotan; Kelly K. Bree; Joan Palou Redorta; David J. McConkey; Byron H. Lee; Paramananthan Mariappan; Laura S. Mertens; Mark S. Soloway; Robert S. Svatek; Wei Shen Tan; Stephen B. Williams; Shilpa Gupta; Roger Buckley; Ashish M. Kamat
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies

低级别非肌层浸润性膀胱癌：分子景观、治疗策略及新兴疗法

Nature Reviews Urology
IF14.6
2025-09-100
PRE
Lexiaochuan Wen; Hiroko Miyagi; Philippe E. Spiess; Alice Yu; Cathy L. Mendelsohn; Wei Shen Tan; Sarah P. Psutka; Seth P. Lerner; Liang Cheng; Lars Dyrskjøt; Joshua J. Meeks; Shahrokh F. Shariat; Paolo Gontero; Benjamin Pradere; Gary D. Steinberg; Ashish M. Kamat; Roger Li
Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy

不适合接受顺铂治疗的肌层浸润性膀胱癌患者，在接受即刻根治性膀胱切除术后显示出较差的长期生存率。

BJU INTERNATIONAL
IF4.4
2025-09-010
PRE
Fazili, Adnan; Jazayeri, Seyed Behzad; Rose, Kyle M.; Guske, Christopher; Wen, Lexiaochuan; Durant, Adri; Prunty, Megan; Bukavina, Laura; Tyson, Mark D.; Grass, G. Daniel; Xu, Hongzhi; Spiess, Philippe E.; Gilbert, Scott M.; Sexton, Wade J.; Zemp, Logan; Pessoa, Rodrigo Rodrigues; Poch, Michael; Lerner, Seth P.; Li, Roger
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer

蛋白质组学表征揭示了与肌肉浸润性膀胱癌化疗耐药相关的生物标志物

Cell Reports Medicine
IF10.6
2025-07-310
OAAI
Matthew V. Holt; Yongchao Dou; Meggie N. Young; Alexander B. Saltzman; Meenakshi Anurag; Jonathan T. Lei; Antrix Jain; Mei Leng; Beom-Jun Kim; Lacey E. Dobrolecki; Stefanie F. Faucher; Sara Savage; Chenwei Wang; Zhiao Shi; Hugo Villanueva; Karoline Kremers; Kyle D. Drinnon; Patricia D. Castro; Michael M. Ittmann; Mehak Mehboob Khatani; Sung Han Kim; Matthew J. Ellis; Bing Zhang; Anna Malovannaya; Seth P. Lerner
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

尿液中肿瘤DNA用于分层评估接受阿替利珠单抗治疗的卡介苗难治性非肌层浸润性膀胱癌患者的复发风险

European Urology
IF25.2
2025-05-220
OAAI
Marie-Pier St-Laurent; Parminder Singh; David J. McConkey; M. Scott Lucia; Vadim S. Koshkin; Kelly L. Stratton; Trinity J. Bivalacqua; Wassim Kassouf; Sima P. Porten; Rick Bangs; Melissa Plets; Ian M. Thompson; Joshua J. Meeks; Vincent M. Caruso; Ceressa T. Ward; Brian C. Mazzarella; Kevin G. Phillips; Vincent T. Bicocca; Trevor G. Levin; Seth P. Lerner; Peter C. Black
BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection
OPEN FORUM INFECTIOUS DISEASES
IF3.8
2025-01-160
OAAI
Longlax, Santiago Carrero; Koster, Kent J.; Kamat, Ashish M.; Lozano, Marisa; Lerner, Seth P.; Hannigan, Rebecca; Nishiguchi, Tomoki; Abhimanyu, Daanish; Sheikh, Daanish; Ladki, Malik; Portillo, Alexandra; Koirala, Amrit; Patel, Tajhal D.; Spieler, Zoe; Benjamin, Aaron B.; Lebedev, Maxim; Ofili, Theresa U.; Hutchison, Robert W.; Udeani, George; Opperman, Lynne A.; Neal, Gabriel; Mandalakas, Anna M.; Netea, Mihai G.; Arditi, Moshe; Avalos, Pablo; Grimm, Sandra L.; Coarfa, Cristian; Cirillo, Jeffrey D.; DiNardo, Andrew R.
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216

体重指数与转移性激素敏感性前列腺癌患者总生存期的相关性：SWOG-1216患者层面数据分析

European Urology Oncology
IF9.3
2024-11-010
PRE
Umang Swami; Yeonjung Jo; Arshit Narang; Melissa Plets; Chadi Hage Chehade; Georges Gebrael; Shilpa Gupta; Zin Myint; Catherine Tangen; Primo N. Lara; Ian M. Thompson; Maha H.A. Hussain; Tanya B. Dorff; Seth P. Lerner; Neeraj Agarwal
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone- sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

3个月和7个月的前列腺特异性抗原水平可作为转移性激素敏感性前列腺癌总生存期的预后指标: SWOG S1216的结果，这是一项雄激素剥夺加Orteronel或比卡鲁胺的3期随机试验

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-10-012
OA
Parikh, Mamta; Tangen, Catherine; Hussain, Maha H. A.; Gupta, Shilpa; Callis, Sam; Jo, Yeonjung; Harzstark, Andrea; Paller, Channing J.; George, Saby; Zibelman, Matthew R.; Cheng, Heather H.; Maughan, Benjamin L.; Zhang, Jingsong; Pachynski, Russell K.; Bryce, Alan H.; Lin, Daniel W.; Quinn, David I.; Lerner, Seth P.; Thompson, Ian M.; Dorff, Tanya B.; Lara, Primo N.; Agarwal, Neeraj
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
EUROPEAN UROLOGY
IF25.2
2024-10-011
PRE
Plimack, Elizabeth R.; Tangen, Catherine; Plets, Melissa; Kokate, Rutika; Xiu, Joanne; Nabhan, Chadi; Ross, Eric A.; Grundy, Erin; Choi, Woonyoung; Dinney, Colin P. N.; Lee, I. -Ling C.; Fong, Megan; Lucia, M. Scott; Daneshmand, Siamak; Theodorescu, Dan; Goldkorn, Amir; Lerner, Seth P.; Flaig, Thomas W.; McConkey, David J.
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer

通过谷氨酰胺代谢激活OXPHOS在非裔美国膀胱癌患者中的线粒体重编程

JCI INSIGHT
IF6.1
2024-09-100
OA
Reddy, Karthik Reddy Kami; Piyarathna, Danthasinghe Waduge Badrajee; Park, Jun Hyoung; Putluri, Vasanta; Amara, Chandra Sekhar; Kamal, Abu Hena Mostafa; Xu, Jun; Kraushaar, Daniel; Huang, Shixia; Jung, Sung Yun; Eberlin, Livia S.; Johnson, Jabril R.; Kittles, Rick A.; Ballester, Leomar Y.; Parsawar, Krishna; Siddiqui, M. Minhaj; Gao, Jianjun; Gramer, Adriana Langer; Bollag, Roni J.; Terris, Martha K.; Lotan, Yair; Creighton, Chad J.; Lerner, Seth P.; Sreekumar, Arun; Kaipparettu, Benny Abraham; Putluri, Nagireddy
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial
EUROPEAN UROLOGY
IF25.2
2024-09-013
PRE
Lara, Primo N., Jr.; Tangen, Catherine; Heath, Elisabeth I.; Gulati, Shuchi; Stein, Mark N.; Meng, Maxwell; Alva, Ajjai Shivaram; Pal, Sumanta K.; Puzanov, Igor; Clark, Joseph I.; Choueiri, Toni K.; Agarwal, Neeraj; Uzzo, Robert; Haas, Naomi B.; Synold, Timothy W.; Plets, Melissa; Vaishampayan, Ulka N.; Shuch, Brian M.; Lerner, Seth; Thompson, Ian M., Jr.; Ryan, Christopher W.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

膀胱内Nadofaragene Firadenovec对卡介苗无反应的非肌层浸润性膀胱癌患者的疗效: 一项3期试验的5年随访

JOURNAL OF UROLOGY
IF6.8
2024-07-0120
OA
Narayan, Vikram M.; Boorjian, Stephen A.; Alemozaffar, Mehrdad; Konety, Badrinath R.; Shore, Neal D.; Gomella, Leonard G.; Kamat, Ashish M.; Bivalacqua, Trinity J.; Montgomery, Jeffrey S.; Lerner, Seth P.; Busby, Joseph E.; Poch, Michael; Crispen, Paul L.; Steinberg, Gary D.; Schuckman, Anne K.; Downs, Tracy M.; Mashni, Joseph; Lane, Brian R.; Guzzo, Thomas J.; Bratslavsky, Gennady; Karsh, Lawrence I.; Woods, Michael E.; Brown, Gordon; Canter, Daniel; Luchey, Adam; Lotan, Yair; Inman, Brant A.; Williams, Michael B.; Cookson, Michael S.; Chang, Sam S.; Sankin, Alexander I.; O'Donnell, Michael A.; Sawutz, David; Philipson, Richard; Parker, Nigel R.; Yla-Herttuala, Seppo; Rehm, Dorte; Jakobsen, Jorn S.; Juul, Kristian; Dinney, Colin P. N.

研究方向

暂未获取到该数据
S
Shahrokh F. Shariat
H 指数:146论文数:2,894被引数:9.9万
Y
Yair Lotan
H 指数:113论文数:1,528被引数:6.0万
P
Pierre I. Karakiewicz
H 指数:109论文数:1,569被引数:4.9万
A
Arthur I. Sagalowsky
H 指数:0论文数:0被引数:28
P
Patrick J. Bastian
H 指数:73论文数:539被引数:1.6万
G
Gilad E. Amiel
H 指数:28论文数:144被引数:4,376
M
Mark Schoenberg
H 指数:64论文数:370被引数:1.3万
R
Robert S. Svatek
H 指数:58论文数:415被引数:1.1万
W
Wassim Kassouf
H 指数:76论文数:735被引数:2.3万
C
Colin P. Dinney
H 指数:98论文数:911被引数:3.3万